TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN UPDATED ANALYSIS OF INFECTION RATES IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAMME

Kevin L. Winthrop  1     Edward V. Loftus Jr.  2     Daniel C. Baumgart  3     Ailsa L Hart  4     OTHMAN ALHARBI  5     Leonardo Salese  6     Nervin Lawendy  6     Rajiv Mundayat  7     Chinyu Su  7     Walter Reinisch  8    
1 Oregon Health & Science University, Portland, United States
2 Mayo Clinic, Rochester, United States
3 University of Alberta, Edmonton, Canada
4 St. Mark's Hospital, London, United Kingdom
5 King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
6 Pfizer Inc, Collegeville, United States
7 Pfizer Inc, New York, United States
8 Medical University of Vienna, Vienna, Austria

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing